- Home
- ACHV vs NXC Comparison
ACHV vs NXC Comparison
Compare ACHV & NXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- NXC
- Stock Information
- Founded
- ACHV N/A
- NXC 1992
- Country
- ACHV Canada
- NXC United States
- Employees
- ACHV N/A
- NXC N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NXC Investment Managers
- Sector
- ACHV Health Care
- NXC Finance
- Exchange
- ACHV Nasdaq
- NXC Nasdaq
- Market Cap
- ACHV 72.5M
- NXC 79.3M
- IPO Year
- ACHV N/A
- NXC N/A
- Fundamental
- Price
- ACHV $3.58
- NXC $12.68
- Analyst Decision
- ACHV Strong Buy
- NXC
- Analyst Count
- ACHV 3
- NXC 0
- Target Price
- ACHV $14.33
- NXC N/A
- AVG Volume (30 Days)
- ACHV 234.9K
- NXC 17.5K
- Earning Date
- ACHV 05-13-2025
- NXC 01-01-0001
- Dividend Yield
- ACHV N/A
- NXC 3.97%
- EPS Growth
- ACHV N/A
- NXC N/A
- EPS
- ACHV N/A
- NXC 0.19
- Revenue
- ACHV N/A
- NXC N/A
- Revenue This Year
- ACHV N/A
- NXC N/A
- Revenue Next Year
- ACHV N/A
- NXC N/A
- P/E Ratio
- ACHV N/A
- NXC $70.47
- Revenue Growth
- ACHV N/A
- NXC N/A
- 52 Week Low
- ACHV $1.84
- NXC $11.86
- 52 Week High
- ACHV $5.58
- NXC $13.70
- Technical
- Relative Strength Index (RSI)
- ACHV 69.97
- NXC 41.26
- Support Level
- ACHV $2.89
- NXC $12.66
- Resistance Level
- ACHV $3.32
- NXC $12.79
- Average True Range (ATR)
- ACHV 0.25
- NXC 0.13
- MACD
- ACHV 0.06
- NXC -0.03
- Stochastic Oscillator
- ACHV 95.12
- NXC 4.17
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About NXC Nuveen California Select Tax-Free Income Portfolio
Nuveen CA Select Tax Free Income Port is a diversified closed-end management investment company. Its objective is to provide stable dividends exempt from both regular federal and California income taxes, consistent with the preservation of capital by investing primarily in municipal obligations.